MSH2 and neoplasm: The differences in the tumor phenotype of the MSH2 and MSH6 deficient mice, and the fact that they have some different functional domains, raises the possibility that disruption of both MSH2 and MSH6 would intensify genomic instability in B or T cells and further impair SHM and CSR.